4-[(1S)-1-[[3-(naphthalen-2-ylmethyl)-7-(1,2,5-oxadiazol-3-yl)indolizine-5-carbonyl]amino]ethyl]benzoic acid

C31H24N4O4 — CID 176772860

IUPAC4-[(1S)-1-[[3-(naphthalen-2-ylmethyl)-7-(1,2,5-oxadiazol-3-yl)indolizine-5-carbonyl]amino]ethyl]benzoic acid
SMILESC[C@H](NC(=O)c1cc(-c2cnon2)cc2ccc(Cc3ccc4ccccc4c3)n12)c1ccc(C(=O)O)cc1
InChIInChI=1S/C31H24N4O4/c1-19(21-8-10-23(11-9-21)31(37)38)33-30(36)29-17-25(28-18-32-39-34-28)16-27-13-12-26(35(27)29)15-20-6-7-22-4-2-3-5-24(22)14-20/h2-14,16-19H,15H2,1H3,(H,33,36)(H,37,38)/t19-/m0/s1
InChIKeyNLKDSVIMLWAVRI-IBGZPJMESA-N
MW516.56 g/mol
LogP5.92
Rot. Bonds7

About 4-[(1S)-1-[[3-(naphthalen-2-ylmethyl)-7-(1,2,5-oxadiazol-3-yl)indolizine-5-carbonyl]amino]ethyl]benzoic acid

4-[(1S)-1-[[3-(naphthalen-2-ylmethyl)-7-(1,2,5-oxadiazol-3-yl)indolizine-5-carbonyl]amino]ethyl]benzoic acid (PubChem CID 176772860) has the molecular formula C31H24N4O4 and a molecular weight of 516.56 g/mol. Its IUPAC name is 4-[(1S)-1-[[3-(naphthalen-2-ylmethyl)-7-(1,2,5-oxadiazol-3-yl)indolizine-5-carbonyl]amino]ethyl]benzoic acid.

Molecular Properties

Compound Name4-[(1S)-1-[[3-(naphthalen-2-ylmethyl)-7-(1,2,5-oxadiazol-3-yl)indolizine-5-carbonyl]amino]ethyl]benzoic acid
PubChem CID176772860
Molecular FormulaC31H24N4O4
Molecular Weight516.56 g/mol
Exact Mass516.18
IUPAC Name4-[(1S)-1-[[3-(naphthalen-2-ylmethyl)-7-(1,2,5-oxadiazol-3-yl)indolizine-5-carbonyl]amino]ethyl]benzoic acid
SMILESC[C@H](NC(=O)c1cc(-c2cnon2)cc2ccc(Cc3ccc4ccccc4c3)n12)c1ccc(C(=O)O)cc1
InChIInChI=1S/C31H24N4O4/c1-19(21-8-10-23(11-9-21)31(37)38)33-30(36)29-17-25(28-18-32-39-34-28)16-27-13-12-26(35(27)29)15-20-6-7-22-4-2-3-5-24(22)14-20/h2-14,16-19H,15H2,1H3,(H,33,36)(H,37,38)/t19-/m0/s1
InChIKeyNLKDSVIMLWAVRI-IBGZPJMESA-N
XLogP5.92
TPSA109.73 Ų
H-Bond Donors2
H-Bond Acceptors6
Rotatable Bonds7
Heavy Atoms39
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500516.56
LogP ≤ 55.92
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 106

Analyze 4-[(1S)-1-[[3-(naphthalen-2-ylmethyl)-7-(1,2,5-oxadiazol-3-yl)indolizine-5-carbonyl]amino]ethyl]benzoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[(1S)-1-[[3-(naphthalen-2-ylmethyl)-7-(1,2,5-oxadiazol-3-yl)indolizine-5-carbonyl]amino]ethyl]benzoic acid?
The IUPAC name of 4-[(1S)-1-[[3-(naphthalen-2-ylmethyl)-7-(1,2,5-oxadiazol-3-yl)indolizine-5-carbonyl]amino]ethyl]benzoic acid (CID 176772860) is 4-[(1S)-1-[[3-(naphthalen-2-ylmethyl)-7-(1,2,5-oxadiazol-3-yl)indolizine-5-carbonyl]amino]ethyl]benzoic acid.
What is the SMILES notation for 4-[(1S)-1-[[3-(naphthalen-2-ylmethyl)-7-(1,2,5-oxadiazol-3-yl)indolizine-5-carbonyl]amino]ethyl]benzoic acid?
The canonical SMILES for 4-[(1S)-1-[[3-(naphthalen-2-ylmethyl)-7-(1,2,5-oxadiazol-3-yl)indolizine-5-carbonyl]amino]ethyl]benzoic acid is C[C@H](NC(=O)c1cc(-c2cnon2)cc2ccc(Cc3ccc4ccccc4c3)n12)c1ccc(C(=O)O)cc1.
What is the InChIKey of 4-[(1S)-1-[[3-(naphthalen-2-ylmethyl)-7-(1,2,5-oxadiazol-3-yl)indolizine-5-carbonyl]amino]ethyl]benzoic acid?
The InChIKey is NLKDSVIMLWAVRI-IBGZPJMESA-N. The full InChI is InChI=1S/C31H24N4O4/c1-19(21-8-10-23(11-9-21)31(37)38)33-30(36)29-17-25(28-18-32-39-34-28)16-27-13-12-26(35(27)29)15-20-6-7-22-4-2-3-5-24(22)14-20/h2-14,16-19H,15H2,1H3,(H,33,36)(H,37,38)/t19-/m0/s1.
What are the key properties of 4-[(1S)-1-[[3-(naphthalen-2-ylmethyl)-7-(1,2,5-oxadiazol-3-yl)indolizine-5-carbonyl]amino]ethyl]benzoic acid?
4-[(1S)-1-[[3-(naphthalen-2-ylmethyl)-7-(1,2,5-oxadiazol-3-yl)indolizine-5-carbonyl]amino]ethyl]benzoic acid has a molecular weight of 516.56 g/mol, XLogP of 5.92, 7 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[(1S)-1-[[3-(naphthalen-2-ylmethyl)-7-(1,2,5-oxadiazol-3-yl)indolizine-5-carbonyl]amino]ethyl]benzoic acid is sourced from PubChem (CID 176772860), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).